Skip to main content
Clinical Trials/CTRI/2020/09/028027
CTRI/2020/09/028027
Recruiting
Phase 2

Efficacy of Rectal Indomethacin in prevention of post-operative pancreatitis after pancreaticoduodenectomy â?? a randomized controlled trial

Institute of Liver and Biliary Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K860- Alcohol-induced chronic pancreatitisHealth Condition 2: K862- Cyst of pancreasHealth Condition 3: C241- Malignant neoplasm of ampulla of VaterHealth Condition 4: C240- Malignant neoplasm of extrahepaticbile ductHealth Condition 5: C250- Malignant neoplasm of head of pancreasHealth Condition 6: K831- Obstruction of bile ductHealth Condition 7: K861- Other chronic pancreatitisHealth Condition 8: K838- Other specified diseases of biliary tract
Sponsor
Institute of Liver and Biliary Sciences
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • All consenting adults planned to undergo pancreatoduodenectomy

Exclusion Criteria

  • 1\. Patients refusing to consent
  • 2\. History of asthma
  • 3\. History of allergic reactions to NSAIDs
  • 4\. History of renal dysfunction or CKD
  • 5\. E/o Internal hemorrhoids on examination
  • 6\. Patients on Anti\-platelet drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials